This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buckler, A J
Right arrow Articles by Housman, D E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buckler, A J
Right arrow Articles by Housman, D E

 Previous Article  |  Next Article 

Mol Cell Biol. 1991 March; 11(3): 1707-1712

Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development.

A J Buckler, J Pelletier, D A Haber, T Glaser and D E Housman

Center for Cancer Research, Massachusetts Institute of Technology, Cambridge 02139.

ABSTRACT

The human Wilms' tumor predisposition gene, WT1, is a Cys-His zinc finger polypeptide which appears to be a transcription factor controlling gene expression during embryonic kidney development. In order to analyze the role of the WT1 gene in nephroblast differentiation, we have isolated the murine homolog of human WT1. An extremely high level of amino acid sequence conservation (greater than 95%) extends throughout all regions of the predicted mouse and human WT1 polypeptides. Two alternative splices within the WT1 transcript have been conserved between mice and humans, suggesting that these have functional significance. Expression of the mouse WT1 mRNA in fetal kidney increases during late gestation, peaks just prior to or shortly after birth, and declines dramatically by 15 days postpartum. Developmental regulation of WT1 expression appears to be selective for the kidney. The restriction of WT1 expression to a limited number of tissues is in contrast to previously described tumor suppressor genes. In addition, the narrow window of time during which WT1 is expressed at high levels in the kidney is consistent with the origin of Wilms' tumor from primitive nephroblasts and the postulated role of this gene as a negative regulator of growth.

Mol Cell Biol. 1991 March; 11(3): 1707-1712




This article has been cited by other articles:

  • Nguyen, A. H.T., Beland, M., Gaitan, Y., Bouchard, M. (2009). Calcineurin A-Binding Protein, a Novel Modulator of the Calcineurin-Nuclear Factor of Activated T-Cell Signaling Pathway, Is Overexpressed in Wilms' Tumors and Promotes Cell Migration. Mol Cancer Res 7: 821-831 [Abstract] [Full Text]  
  • Kuball, J., Hauptrock, B., Malina, V., Antunes, E., Voss, R.-H., Wolfl, M., Strong, R., Theobald, M., Greenberg, P. D. (2009). Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain. JEM 206: 463-475 [Abstract] [Full Text]  
  • Morrison, A. A., Viney, R. L., Saleem, M. A., Ladomery, M. R. (2008). New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Am. J. Physiol. Renal Physiol. 295: F12-F17 [Abstract] [Full Text]  
  • Narlis, M., Grote, D., Gaitan, Y., Boualia, S. K., Bouchard, M. (2007). Pax2 and Pax8 Regulate Branching Morphogenesis and Nephron Differentiation in the Developing Kidney. J. Am. Soc. Nephrol. 18: 1121-1129 [Abstract] [Full Text]  
  • Horiuchi, K., Umetani, M., Minami, T., Okayama, H., Takada, S., Yamamoto, M., Aburatani, H., Reid, P. C., Housman, D. E., Hamakubo, T., Kodama, T. (2006). Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA. Proc. Natl. Acad. Sci. USA 103: 17278-17283 [Abstract] [Full Text]  
  • Grote, D., Souabni, A., Busslinger, M., Bouchard, M. (2006). Pax2/8-regulated Gata3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development 133: 53-61 [Abstract] [Full Text]  
  • Srichai, M. B., Konieczkowski, M., Padiyar, A., Konieczkowski, D. J., Mukherjee, A., Hayden, P. S., Kamat, S., El-Meanawy, M. A., Khan, S., Mundel, P., Lee, S. B., Bruggeman, L. A., Schelling, J. R., Sedor, J. R. (2004). A WT1 Co-regulator Controls Podocyte Phenotype by Shuttling between Adhesion Structures and Nucleus. J. Biol. Chem. 279: 14398-14408 [Abstract] [Full Text]  
  • Discenza, M. T., Pelletier, J. (2004). Insights into the physiological role of WT1 from studies of genetically modified mice. Physiol. Genomics 16: 287-300 [Abstract] [Full Text]  
  • Logan, K. A., McNatty, K. P., Juengel, J. L. (2003). Expression of Wilms' Tumor Gene and Protein Localization During Ovarian Formation and Follicular Development in Sheep. Biol. Reprod. 68: 635-643 [Abstract] [Full Text]  
  • Natoli, T. A., McDonald, A., Alberta, J. A., Taglienti, M. E., Housman, D. E., Kreidberg, J. A. (2002). A Mammal-Specific Exon of WT1 Is Not Required for Development or Fertility. Mol. Cell. Biol. 22: 4433-4438 [Abstract] [Full Text]  
  • Elisseeva, O. A., Oka, Y., Tsuboi, A., Ogata, K., Wu, F., Kim, E. H., Soma, T., Tamaki, H., Kawakami, M., Oji, Y., Hosen, N., Kubota, T., Nakagawa, M., Yamagami, T., Hiraoka, A., Tsukaguchi, M., Udaka, K., Ogawa, H., Kishimoto, T., Nomura, T., Sugiyama, H. (2002). Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies. Blood 99: 3272-3279 [Abstract] [Full Text]  
  • Zhang, F., Nakanishi, G., Kurebayashi, S., Yoshino, K., Perantoni, A., Kim, Y.-S., Jetten, A. M. (2002). Characterization of Glis2, a Novel Gene Encoding a Gli-related, Kruppel-like Transcription Factor with Transactivation and Repressor Functions. ROLES IN KIDNEY DEVELOPMENT AND NEUROGENESIS. J. Biol. Chem. 277: 10139-10149 [Abstract] [Full Text]  
  • Guo, J.-K., Menke, A. L., Gubler, M.-C., Clarke, A. R., Harrison, D., Hammes, A., Hastie, N. D., Schedl, A. (2002). WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet 11: 651-659 [Abstract] [Full Text]  
  • WAGNER, K.-D., WAGNER, N., SUKHATME, V. P., SCHOLZ, H. (2001). Activation of Vitamin D Receptor by the Wilms' Tumor GeneProduct Mediates Apoptosis of Renal Cells. J. Am. Soc. Nephrol. 12: 1188-1196 [Abstract] [Full Text]  
  • MROWKA, C., SCHEDL, A. (2000). Wilms' Tumor Suppressor Gene WT1: From Structure to Renal Pathophysiologic Features. J. Am. Soc. Nephrol. 11: S106-S115 [Abstract] [Full Text]  
  • Little, N. A., Hastie, N. D., Davies, R. C. (2000). Identification of WTAP, a novel Wilms' tumour 1-associating protein. Hum Mol Genet 9: 2231-2239 [Abstract] [Full Text]  
  • Gaiger, A., Reese, V., Disis, M. L., Cheever, M. A. (2000). Immunity to WT1 in the animal model and in patients with acute myeloid leukemia. Blood 96: 1480-1489 [Abstract] [Full Text]  
  • Ladomery, M. R., Slight, J., Mc Ghee, S., Hastie, N. D. (1999). Presence of WT1, the Wilm's Tumor Suppressor Gene Product, in Nuclear Poly(A)+ Ribonucleoprotein. J. Biol. Chem. 274: 36520-36526 [Abstract] [Full Text]  
  • Scharnhorst, V., Dekker, P., van der Eb, A. J., Jochemsen, A. G. (1999). Internal Translation Initiation Generates Novel WT1 Protein Isoforms with Distinct Biological Properties. J. Biol. Chem. 274: 23456-23462 [Abstract] [Full Text]  
  • Patek, C. E., Little, M. H., Fleming, S., Miles, C., Charlieu, J.-P., Clarke, A. R., Miyagawa, K., Christie, S., Doig, J., Harrison, D. J., Porteous, D. J., Brookes, A. J., Hooper, M. L., Hastie, N. D. (1999). A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc. Natl. Acad. Sci. USA 96: 2931-2936 [Abstract] [Full Text]  
  • Yang, Y., Jeanpierre, C., Dressler, G. R., Lacoste, M., Niaudet, P., Gubler, M.-C. (1999). WT1 and PAX-2 Podocyte Expression in Denys-Drash Syndrome and Isolated Diffuse Mesangial Sclerosis. Am. J. Pathol. 154: 181-192 [Abstract] [Full Text]  
  • Zhan, Q., Chen, I-T., Antinore, M. J., Fornace, A. J. Jr. (1998). Tumor Suppressor p53 Can Participate in Transcriptional Induction of the GADD45 Promoter in the Absence of Direct DNA Binding. Mol. Cell. Biol. 18: 2768-2778 [Abstract] [Full Text]  
  • Smith, S. I., Weil, D., Johnson, G. R., Boyd, A. W., Li, C. L. (1998). Expression of the Wilms' Tumor Suppressor Gene, WT1, Is Upregulated by Leukemia Inhibitory Factor and Induces Monocytic Differentiation in M1 Leukemic Cells. Blood 91: 764-773 [Abstract] [Full Text]  
  • Drummond, I., Majumdar, A, Hentschel, H, Elger, M, Solnica-Krezel, L, Schier, A., Neuhauss, S., Stemple, D., Zwartkruis, F, Rangini, Z, Driever, W, Fishman, M. (1998). Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function. Development 125: 4655-4667 [Abstract]  
  • Scholz, H., Bossone, S. A., Cohen, H. T., Akella, U., Strauss, W. M., Sukhatme, V. P. (1997). A Far Upstream Cis-element Is Required for Wilms' Tumor-1 (WT1) Gene Expression in Renal Cell Culture. J. Biol. Chem. 272: 32836-32846 [Abstract] [Full Text]  
  • Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., Tatekawa, T., Soma, T., Kishimoto, T., Sugiyama, H. (1997). Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia. Blood 89: 1405-1412 [Abstract] [Full Text]  
  • Cohen, H. T., Bossone, S. A., Zhu, G., McDonald, G. A., Sukhatme, V. P. (1997). Sp1 Is a Critical Regulator of the Wilms' tumor-1 Gene. J. Biol. Chem. 272: 2901-2913 [Abstract] [Full Text]  
  • Bruening, W., Pelletier, J. (1996). A Non-AUG Translational Initiation Event Generates Novel WT1 Isoforms. J. Biol. Chem. 271: 8646-8654 [Abstract] [Full Text]  
  • Reddy, J. C., Hosono, S., Licht, J. D. (1995). The Transcriptional Effect of WT1 Is Modulated by Choice of Expression Vector. J. Biol. Chem. 270: 29976-29982 [Abstract] [Full Text]  
  • Hewitt, S. M., Fraizer, G. C., Saunders, G. F. (1995). Transcriptional Silencer of the Wilms' Tumor Gene WT1 Contains an Alu Repeat. J. Biol. Chem. 270: 17908-17912 [Abstract] [Full Text]  
  • Reddy, J. C., Morris, J. C., Wang, J., English, M. A., Haber, D. A., Shi, Y., Licht, J. D. (1995). WT1-mediated Transcriptional Activation Is Inhibited by Dominant Negative Mutant Proteins. J. Biol. Chem. 270: 10878-10884 [Abstract] [Full Text]  
  • Coppes, M. J., Haber, D. A., Grundy, P. E. (1994). Genetic Events in the Development of Wilms' Tumor. NEJM 331: 586-590 [Full Text]  
  • Haber, D., Park, S, Maheswaran, S, Englert, C, Re, G., Hazen-Martin, D., Sens, D., Garvin, A. (1993). WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science 262: 2057-2059 [Abstract]  
  • Mundlos, S., Pelletier, J., Darveau, A., Bachmann, M., Winterpacht, A., Zabel, B. (1993). Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development 119: 1329-1341 [Abstract]  
  • Madden, S., Cook, D., Morris, J., Gashler, A, Sukhatme, V., Rauscher, F. III (1991). Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 253: 1550-1553 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»